Abstract Background The Infectious Diseases Society of America is committed to providing
up-to-date guidance on the treatment of antimicrobial-resistant infections. This guidance …

Abstract The Infectious Diseases Society of America (IDSA) is committed to providing up-to-
date guidance on the treatment of antimicrobial-resistant infections. A previous guidance …

Stenotrophomonas maltophilia is an opportunistic pathogen of significant concern to
susceptible patient populations. This pathogen can cause nosocomial and community …

Stenotrophomonas maltophilia is a non-fermenting, Gram-negative bacillus that has
emerged as an opportunistic nosocomial pathogen. Its intrinsic multidrug resistance makes …

Stenotrophomonas maltophilia is an urgent global threat due to its increasing incidence and
intrinsic antibiotic resistance. Antibiotic development has focused on carbapenem-resistant …

Objectives Stenotrophomonas maltophilia (S. maltophilia), an opportunistic pathogen,
causes infection in patients undergoing immunosuppressive therapy, mechanical …

Abstract Background Trimethoprim-sulfamethoxazole (TMP-SMX) is considered first-line
therapy for Stenotrophomonas maltophilia infections based on observational data from small …

Stenotrophomonas maltophilia is an opportunistic pathogen that results in nosocomial
infections in immunocompromised individuals. These bacteria colonize on the surface of …

Abstract Introduction Infections caused by Stenotrophomonas maltophilia are clinically
important due to its intrinsic resistance to a broad range of antibiotics. Therefore, selecting …

Stenotrophomonas maltophilia is a multidrug-resistant organism that is emerging as an
important opportunistic pathogen. Despite this, information on the epidemiology and …